Abstract
SK-N-SH cells exposed to low ratios of ICP0-null (ΔICP0) mutants of herpes simplex virus per cell express the viral α proteins, but the progression to β and γ gene expression does not ensue. In these restrictive cells, post-α gene expression can be induced after exposure of the infected cells to sodium butyrate, an indication that VP16 brought into cells by the virus and the α gene products made after infection cannot block the silencing of viral post-α genes by histone deacetylases (HDACs). This observation is consistent with evidence reported earlier that ICP0 dissociates HDAC1/2 from the CoREST/REST complex. In permissive U2OS cells, replication is independent of the ratio of ΔICP0 mutant per cell. To determine whether other viral genes are involved in blocking HDACs, we used a surrogate system consisting of baculoviruses carrying viral or cellular genes driven by CMV immediate–early promoter. Expression of these genes requires blocking of histone deacetylation. We report that (i) cotransduced US3 or US3.5 protein kinase substitutes for sodium butyrate in enabling the expression of a reporter gene in restrictive cells and enhancing it in permissive cells; (ii) HDAC1 is phosphorylated concomitant with the expression of reporter genes; and (iii) the amounts and appearance of HDAC1 are altered in transduced cells expressing US3 protein kinase in the absence of other viral proteins. We conclude that the US3 protein kinase blocks histone deacetylation by a mechanism distinct from that of ICP0 and that debilitated histone deacetylation contributes to the permissiveness of U2OS cells for ΔICP0 mutants.
Keywords: histone deacetylases
The central theme of this article is that, immediately upon release of herpes simplex virus (HSV) 1 DNA from capsids, a competition ensues between cellular factors whose mission is to silence viral DNA and viral proteins that aim to block the cell. In cells infected at low ratios of wild-type virus per cell, α-transinducing factor (or VP16) transactivates α genes, the first set to be expressed after infection. Of the six α proteins (ICP0, ICP4, US1.5, ICP22, ICP27, and ICP47), two, ICP4 and ICP0, are required for expression of β genes. ICP4 represses its own gene and other genes and most likely recruits host factors to the machinery that transcribes viral DNA (1). In cells infected at low ratios of infectious virus per cell, viral replication takes place in a few cell lines (e.g., U2OS cells) but is blocked in most cell lines (e.g., SK-N-SH and Vero cells) (2–5). Numerous reports have shown that herpes viral gene expression depends on the inhibition of histone deacetylases (HDACs) (5–11). Association of ICP0 orthologs with HDACs has been reported for other herpesviruses (12). The equivalent functions of ICP0 have been reported for immediate–early protein 1 of murine and human cytomegaloviruses, respectively (13, 14). In an earlier report we showed that ICP0 interacts with the complex CoREST/REST/HDAC1/2 and dissociates the HDACs from the complex (15).
In this report we present evidence that ICP0 enables the transition from α to β gene expression by blocking histone deacetylation inasmuch as in SK-N-SH cells exposed to low ratios of ΔICP0 plaque-forming units (pfu) per cell, sodium butyrate, a HDAC inhibitor, complements the mutant in enabling post-α gene expression. We report that HSV-1-encoded protein kinases US3 and US3.5 also act to block histone deacetylation. Finally, we show that, in SK-N-SH cells that restrict post-α gene expression, the US3 protein kinase mediates the phosphorylation and rearrangement of HDAC1. The results suggest that the permissivity of U2OS cells for ΔICP0 mutants may reflect the regulation of HDAC1/2 in U2OS cells.
Relevant to this report are the following: Both ICP0 and the US3 protein kinase are multifunctional proteins (1). ICP0 is a 775-residue protein encoded in three exons (16). An important biologic activity of ICP0 is that it transactivates genes introduced by infection or transfection but does not bind DNA (17–19). In addition to the functions described in this and the earlier report (15), ICP0 also blocks interferon (IFN) pathway signaling (20–22). One of the pathways by which ICP0 blocks antiviral responses activated by IFN is to degrade PML (promyelocytic leukemia protein) and SP100 and to disperse the ND10 nuclear structures inasmuch as the antiviral effects of exogenous IFN are signaled through ND10 nuclear structures (23). ICP0 ubiquitin ligase activity mapping in exon II causes degradation of PML and dispersal of ND10 structures, thereby blocking the IFN signaling pathway (16).
Imbedded in the transcriptional unit for the US3 protein kinase is a small transcriptional unit encoding a shorter, carboxyl-terminal, colinear US3.5 protein (24). Both US3 and US3.5 act as protein kinases targeting amino acid residues similar to those phosphorylated by protein kinase A (PKA) (25). Both US3 and US3.5 kinases mediate the phosphorylation of HDAC1 and HDAC2 (24, 26, 27). Whereas the US3 protein kinase blocks apoptosis induced by defective viruses or exogenous agents, the US3.5 enzyme does not (27–32).
Results
In SK-N-SH Cells Infected at Low Multiplicity of Infection with the ΔICP0 Mutant Virus, the Expression of ICP8, a β Gene, Requires Inhibition of Histone Deacetylation.
SK-N-SH or U2OS cells grown on four-well slides were exposed to 0, 1, 5, or 20 mM sodium butyrate 1 h before infection with 0.005 pfu of ΔICP0 virus per cell (titer was determined on U2OS cells). At 18 h after infection, the cells were fixed and reacted first with polyclonal anti-CoREST antibody and monoclonal anti-ICP4 or anti-ICP8 antibody and subsequently with FITC-conjugated anti-rabbit and Texas red-conjugated anti-mouse antibodies. Approximately 200 cells illuminated by the anti-CoREST antibody were counted with the aid of a Zeiss confocal microscope, and the percentage of cells expressing ICP4 or ICP8 was determined. The results (Fig. 1A and B) were as follows.
Fig. 1.
Sodium butyrate enables expression of ICP8 in SK-N-SH cells exposed to ΔICP0 mutant virus and enhances expression of transduced genes in SK-N-SH and U2OS cells. (A and B) SK-N-SH or U2OS cells seeded on four-well slides were exposed to concentrations of sodium butyrate shown for 1 h and then infected with 0.005 pfu of ΔICP0 virus per cell. At 18 h after infection the slides were fixed and reacted with polyclonal anti-CoREST plus monoclonal anti-ICP4 (A) or anti-ICP8 (B) antibodies. Secondary antibodies were FITC-conjugated anti-rabbit and Texas red-conjugated anti-mouse antibodies. The images collected with a Zeiss confocal microscope at ×40 were tabulated, and the percentages of cells expressing ICP4 or ICP8 were determined. (C) SK-N-SH and U2OS cells seeded on four-well slides exposed to sodium butyrate as shown were transduced with baculovirus expressing myc-tagged UL34. After 9 h of incubation the cells were fixed and reacted with polyclonal anti-CoREST and monoclonal anti-myc antibodies. Images collected as above were tabulated, and percentages of cells expressing myc-tagged UL34 were determined. (D) SK-N-SH and U2OS cells grown in 25-cm2 flasks were transduced with 10 pfu of baculovirus carrying myc-tagged UL34 per cell at shown concentration of sodium butyrate for 24 h. The cells were lysed, electrophoretically separated on 10% denaturing polyacrylamide gel, and reacted with monoclonal anti-myc antibody as described previously (43).
In the absence of sodium butyrate, 19% of total infected SK-N-SH cells expressed ICP4, and only 2.6% expressed ICP8. At the optimal dose of sodium butyrate (5 mM), the number of ICP4-positive cells increased to 36%, whereas the number of ICP8-positive cells increased to 16%. Thus, sodium butyrate increased the number of ICP4-positive cells ≈2-fold and that of ICP8-expressing cells 6-fold. We may conclude from these results that, in SK-N-SH cells, the expression of α genes and especially that of β genes is enhanced by inhibitors of histone deacetylation.
In contrast to the results obtained with SK-N-SH cells, the number of U2OS cells expressing ICP4 and ICP8 (58% and 27%, respectively) was significantly higher, and these numbers did not increase significantly in cells exposed to sodium butyrate. We conclude from this experiment that inhibition of histone deacetylation is critical for the expression of ICP8 in SK-N-SH cells but not in U2OS cells and that sodium butyrate compensates at least in part for the absence of ICP0 in SK-N-SH cells.
Expression of Genes Transduced with the Aid of Baculoviruses also Requires Inhibition of Histone Deacetylation.
Genes driven by CMV immediate–early promoter and carried by baculoviruses can be expressed in mammalian cells. In most cell lines tested, the expression of the inserted gene required inhibition of histone-deacetylating enzymes (33). The following experiments were designed to compare the requirement for inhibiting histone deacetylating enzymes in SK-N-SH and U2OS cells.
In the first series, SK-N-SH and U2OS cells grown on four-well slides exposed for 1 h to BC2901 expressing a myc-tagged UL34 (40 pfu per cell) were incubated for 9 h in medium containing 0–20 mM sodium butyrate, then fixed and reacted with monoclonal anti-myc antibody for detection of the UL34 protein and polyclonal anti-CoREST antibody to visualize the fixed cells. As shown in Fig. 1C, <2% of SK-N-SH cells transduced with BC2901 expressed UL34 protein in the absence of sodium butyrate as compared with 20% of cells exposed to 10 mM sodium butyrate. In contrast, between 65% and 75% of U2OS cells transduced with BC2901 expressed UL34 protein in a manner independent of the concentration of sodium butyrate.
In the next series of experiments, electrophoretically separated proteins from replicate cultures of SK-N-SH or U2OS cells transduced with BC2901 (10 pfu per cell) and maintained for 24 h in medium containing 0–20 mM sodium butyrate were reacted with anti-myc antibody. The results (Fig. 1D) were that only trace amounts of the myc-tagged UL34 protein accumulated in untreated SK-N-SH cells in contrast to huge amounts detectable in U2OS cells. Sodium butyrate caused an increase in the accumulation of UL34 protein in both cell lines. But, even at the most effective dose of sodium butyrate, the amount of myc-tagged protein accumulating in SK-N-SH cells was lower than the amount detected in untreated U2OS cells. We conclude the following: (i) Optimal expression of genes introduced by transduction into SK-N-SH and U2OS cells requires inhibition of histone-deacetylating enzymes. This requirement is more stringent for SK-N-SH cells than for U2OS cells, suggesting that either histone deacetylation is more active in SK-N-SH cells or defective in U2OS cells. (ii) While the number of U2OS cells capable of expressing transduced genes was higher than in SK-N-SH cells, this number remained constant independent of sodium butyrate concentration. Nevertheless, inhibition of histone deacetylation was essential for optimal expression of the transduced gene. The results suggest the possibility that the total fraction of cells capable of expressing UL34 was limited and independent of inhibition of deacetylation by sodium butyrate. The situation appears to be different in SK-N-SH cells in that both the amount of UL34 protein and number of cells accumulating the protein required inhibition of histone deacetylation. Furthermore, because the number of SK-N-SH cells expressing UL34 protein was relatively low and sodium butyrate-dose dependent, the results suggest that some SK-N-SH cells were incapable of expressing UL34 protein even under the highest concentrations of sodium butyrate.
The US3 Gene Can Substitute for Sodium Butyrate for Expression of Baculovirus-Mediated Transduction of Reporter Gene.
Viral protein kinase US3 mediates the phosphorylation of histone-deacetylating enzymes HDAC1 and HDAC2 (24, 26). In this series of experiments, the expression of four reporter genes encoded in baculoviruses was investigated in SK-N-SH and U2OS cells in the presence or absence of sodium butyrate and compared to cotransduction with the US3 gene. The results (Fig. 2) were as follows.
Fig. 2.
US3 substitutes for sodium butyrate in enhancing reporter gene expression. Replicate cultures of U2OS (lanes 1–8) or SK-N-SH cells (9–16) in 25-cm2 flasks were exposed to insect cell medium (lanes 7, 8, 15, and 16), 8 pfu per cell of BC2619 expressing cdc34, 2 pfu per cell of BC2620 expressing HDAC4, 2 pfu per cell of BC2618 expressing US11, or 2 pfu per cell of BC2617 expressing US1.5 (lanes 1, 2, 9, and 10) alone, or mixture containing 8, 4, 2, or 1 pfu per cell of BC2602 expressing Flag-tagged wild-type US3 (lanes 3–6 and 11–14). After 1 h the inoculum was replaced with medium supplemented with 10% newborn bovine serum (lanes 1–8) or FBS (lanes 9–16) in the presence (lanes 1, 8, 9, and 16) or absence (lanes 2–7 and 10–15) of 6 mM sodium butyrate. The cells were harvested at 22 h after transduction, rinsed three times with PBS containing protease inhibitor mixture (Roche), and then solubilized in 150 μl of disruption buffer (50 mM Tris·HCl, pH 7/2% SDS/710 mM 2-mercaptoethanol/3% sucrose). Portions (50 μl) of lysates were boiled for 5 min, and the solubilized proteins were subjected to electrophoresis in 11% (A, B, and D) or 12% (C) denaturing polyacrylamide gel, transferred to nitrocellulose sheets, blocked with 5% nonfat milk, reacted with mouse monoclonal antibody against the Flag epitope (for detection of US3, cdc34, and HDAC4 in A and B) or US11 (C), or rabbit polyclonal antibody W2 against US1.5 (D), followed by appropriate secondary antibody conjugated to alkaline phosphatase (Bio-Rad), and visualized according to the manufacturer’s instructions.
In SK-N-SH cells, the products of the transduced reporter genes either failed to accumulate (e.g., US1.5) or accumulated at a low level (cdc34, HDAC4, or US11) in the absence of either sodium butyrate or US3. In each test, sodium butyrate produced maximum accumulation of the reporter gene product (Fig. 2, lane 9). US3 enabled the accumulation of reporter proteins to levels above those obtained in the absence of any treatment. In the case of cdc34 and HDAC4, the highest accumulation of the reporter proteins was in cells transduced with the lowest amounts of Bac-US3 (1 pfu per cell). The overall impression is that, at 8 pfu of Bac-US3 per cell, the yields of reporter proteins were lower than in cells transduced with lower ratios of Bac-US3 per cell. The largest amounts of HDAC4 and US11 obtained in cells cotransduced with Bac-US3 were comparable to those obtained in cells treated with sodium butyrate. In U2OS cells, the amounts of some reporter proteins produced in cells cotransduced with 8 pfu of Bac-US3 per cell (e.g., HDAC4 and cdc34) were lower than in cells transduced with lower ratios of Bac-US3 per cell, whereas others (e.g., US1.5) were optimal at 4 pfu per cell but were reduced at either higher or lower ratios of Bac-US3 per cell. As a general rule, at ratios <8 Bac-US3 pfu per cell, the expression of the reporter genes was US3-dose-dependent. At high ratios of Bac-US3 pfu per cell, US3 may be toxic to the transduced cells. The largest accumulations of reporter proteins in cells cotransduced with US3 were comparable to those obtained in cells exposed to sodium butyrate.
The key conclusion of the results shown in Fig. 2 is that US3 protein kinase can substitute for sodium butyrate to enable expression of genes introduced into cells by transduction at relatively low multiplicities of infection.
US3 Is More Effective If Transduced into Cells Several Hours Before the Transduction of the Reporter Gene.
This series of experiments was done in two parts. In the first (Fig. 3A) U2OS cells were exposed to insect cell medium or transduced singly or cotransduced with baculovirus encoding Flag-tagged wild-type US3 (0, 0.5, 1, 2, or 4 pfu per cell) or HDAC4 (2 pfu per cell) and processed as described in the legend to Fig. 3. In the second part (Fig. 3B) the experiment was repeated by using baculoviruses encoding US3 (1 pfu per cell) or HDAC4 (2 pfu per cell). In addition, two cultures transduced and maintained for 6 h or 3 h with US3 were then transduced with HDAC4. The salient features of the results (Fig. 3) were as follows. (i) The expression of the reporter gene HDAC4 in U2OS cells was US3-dose-dependent. (ii) Expression of HDAC4 was vastly higher in cells transduced with US3 3 or 6 h before transduction with HDAC4 than in cells cotransduced with US3 and HDAC4. (iii) HDAC1 was posttranslationally modified in all cell cultures transduced with US3 alone or in combination with HDAC4 independent of the dose of US3.
Fig. 3.
US3 is more effective if transduced into cells several hours before transduction of reporter gene. (A) Cotransduction. Replicate cultures of U2OS were exposed for 1 h to insect cell medium (lane 1), to 4, 2, 1, or 0.5 pfu of BC2602 expressing Flag-tagged wild-type US3 (lanes 2–5) per cell alone, to a mixture containing 2 pfu per cell of BC2620 expressing HDAC4 (lanes 7–10), or to 2 pfu per cell of BC2620 alone (lane 6), then maintained for 24 h in 10% serum, harvested, and processed as described in the legend to Fig. 2. The electrophoretically separated proteins were reacted with mouse monoclonal antibody against the Flag epitope (for detection of US3 and HDAC4) or rabbit polyclonal antibody against HDAC1, as described in the legend to Fig. 2. (B) Preactivation. Replicate cultures of U2OS were exposed to 1 pfu per cell of BC2602 expressing Flag-tagged wild-type US3 alone (lane 5), 2 pfu per cell of BC2620 expressing HDAC4 alone (lane 4), or mixture containing both BC2602 and BC2620 (lane 3). Two cultures preexposed for 6 h (lane 1) or 3 h (lane 2) to 1 pfu per cell of BC2602 were also transduced with 2 pfu per cell of BC2620 expressing HDAC4. Cells were maintained in 10% serum for 21 h, then harvested and processed as described above.
The Kinase Activity of US3 Is Essential for Expression of the Reporter Gene Transduced into U2OS Cells.
Replicate cultures of U2Os cells were exposed to insect cell medium, empty baculovirus, or baculoviruses encoding Flag-tagged US3, Flag-tagged US3.5, or K220N mutant of US3 (8, 4, or 2 pfu per cell). Five hours later they were transduced with US11 (2 pfu per cell), maintained for 22 h in the presence or absence of 6 mM sodium butyrate, and then harvested and processed as described in the legend to Fig. 4. The results (Fig. 4A) were as follows. (i) The amounts of accumulation of wild-type US3 protein was greater than that of the mutant US3 protein in cells exposed to the same number of pfu (compare lanes 10–12 with lanes 13–15). The most likely explanation is that US3 enhances its own gene expression. (ii) The amounts of US11 protein accumulating in transduced cells preactivated with the mutant US3 gene (lanes 13–15) were small and were not much greater than that accumulated in cells preactivated with the empty baculovirus (lanes 1–3). In contrast, appreciable amounts of US11 protein accumulated in transduced cells preactivated by either wild-type US3 (lanes 10–12) or US3.5 (lanes 7–9) at levels higher than that accumulated in cells treated with sodium butyrate (lane 6). (iii) HDAC1 was posttranslationally modified in all cell cultures cotransduced with the wild-type US3 (lanes 10–12) or US3.5 (lanes 6–9) but not the mutant US3 gene (lanes 13–15). These results suggest that the expression of US3 and of the reporter gene US11 required a functional US3 kinase domain.
Fig. 4.
The US3 kinase activity is required for enhancement of gene expression. (A) Replicate cultures of U2OS cells were exposed to insect cell medium (lanes 4–6), 8, 4, or 2 pfu per cell of BC2623 (control baculovirus; lanes 1–3), BC2608 (expresses Flag-tagged wild-type US3.5; lanes 7–9), BC2602 (expresses Flag-tagged wild-type US3; lanes 10–12), or BC2621 (expresses K220N-mutant US3; lanes 13–15) for 1 h, then maintained in medium supplemented with 10% FBS. Five hours later the cells were transduced with 2 pfu per cell of BC2618 (expresses US11; all lanes except lane 4). The cultures were maintained for 22 h in 10% serum in the presence (lane 6) or absence (lanes 1–5 and 7–15) of 6 mM sodium butyrate, then harvested and processed as described in the legend to Fig. 2. The electrophoretically separated proteins were reacted with monoclonal antibody against US11 or polyclonal antibody against US3 or HDAC1. (B) Replicate cultures of U2OS cells were exposed for 1 h to insect cell medium (lanes 1–4), to lower ratios of pfu of BC2602 (expresses Flag-tagged wild-type US3; lanes 5–10) per cell, or to 8, 4, or 2 pfu of BC2621 (expresses K220N-mutant US3; lanes 11–13) per cell, maintained in 10% serum for 5 h, and then transduced with 2 pfu per cell of BC2618 (expresses US11; all lanes except lanes 1,2). Cultures were maintained for 22 h in 10% serum in the presence (lanes 1 and 3) or absence (lanes 2 and 4–13) of 6 mM sodium butyrate, then harvested and processed as described above.
The results of the experiment described above did not exclude the possibility that the absence of US11 protein was due to the low level of expression of US3 mutant protein rather than the lack of kinase function. In the experiment shown in Fig. 4B, the cells were transduced with lower ratios of wild-type US3 (2, 1, 0.5, 0.25, 0.125, or 0.06 pfu per cell) to enable comparison of cultures expressing equal amounts of mutant protein. The results (Fig. 4B) were as follows. (i) Comparison of cultures expressing equal amounts of wild-type and mutant US3 (e.g., lanes 7 and 11) shows that US11 accumulation was higher in cells transduced with the wild-type US3 gene. (ii) The amounts of US11 accumulating in cells transduced with the smallest doses of wild-type US3 were higher than in cells transduced with the mutant US3 gene (compare lanes 9 and 10 with lanes 11–13). (iii) HDAC1 was posttranslationally modified in all cell cultures cotransduced with the wild-type gene (lanes 5–10) but not the mutant US3 gene (lanes 11–13). The key conclusion is that the kinase activity of US3 is necessary for the enhancement of expression of transduced reporter genes.
Changes in the Appearance and Distribution of HDAC1 Correlated with Accumulation of the US3 Protein Kinase.
SK-N-SH or U2OS cells seeded on four-well slides were mock-transduced or transduced with baculovirus BC2623 expressing myc-tagged US3, fixed 20 h after transduction, and then reacted with polyclonal anti-HDAC1 and monoclonal anti-myc antibodies followed by FITC-conjugated goat anti-rabbit and Texas red-conjugated goat anti-mouse antibodies. Images were collected with a Zeiss confocal microscope. The striking feature observed in this (Fig. 5) and other experiments was that SK-N-SH cells formed two populations, one with prominent amounts of HDAC1 and the other with little or no HDAC1. In contrast, the distribution of HDAC1 in U2OS cells was relatively uniform. Moreover, in SK-N-SH cells transduced with US3 and expressing the viral protein kinase, the amounts of HDAC1 were low or barely detectable in contrast to cells not expressing the kinase. In U2OS cells transduced with US3 and expressing the viral protein kinase, the intensity of HDAC1 fluorescence was decreased and had a speckled appearance but did not vary much from cell to cell. It is not clear whether US3 was expressed preferentially in SK-N-SH cells containing less HDAC1 or whether cells that were transduced ended up with less HDAC1 irrespective of the amounts present at the time of transduction. In a duplicate experiment the monoclonal antibody against HDAC1 was also tested to ensure that these observations did not reflect the properties of specific antibodies, and the same results were obtained.
Fig. 5.
Distribution of HDAC1 in cells expressing baculovirus transduced with US3. SK-N-SH and U2OS cells seeded on four-well slides were mock-transduced or transduced with myc-tagged US3. After 20 h of transduction, cells were fixed and treated as described in Fig. 1. The slides were incubated with polyclonal anti-HDAC1 plus monoclonal anti-myc antibodies and then reacted to FITC-conjugated goat anti-rabbit plus Texas red-conjugated goat anti-mouse antibodies.
Discussion
The evidence collected in the past three decades indicates that, upon release of viral DNA from capsids into the nucleus, α-transinducing factor (VP16) activates the transcription of α genes. The six products of the initial transcription are ICP0, US1.5, ICP4, ICP22, ICP27, and ICP47. Expression of β and γ genes ensues. At low multiplicity of infection, the transition from α to β and γ protein synthesis requires ICP0 and ICP4. In the absence of ICP0, the four regulatory proteins ICP4, ICP22, US1.5, and ICP27 enable viral gene expression in a few selected cell lines exemplified by U2OS cells but not in most cell lines exemplified by SK-N-SH cells (2, 4, 16). Central to the understanding of the mechanism by which the virus insures the expression of its genes is the role of ICP0 in enabling the expression of post-α genes and also why it is critical in cells exemplified by SK-N-SH cells and not in U2OS cells. The model we propose is as follows.
On entry of the viral DNA into the nucleus, a competition ensues between cellular proteins that attempt to silence the viral genome and viral gene products, which ensure that viral gene expression is unencumbered. As noted above, α genes are transactivated by α-transinducing factor, whereas β genes require both ICP4 and ICP0 for their expression. We propose that HSV encodes two proteins, ICP0 and US3, that independently block silencing of viral DNA to enable the transition from α to β gene expression.
The role of ICP0 is apparent from three series of experiments. First, this laboratory reported that the expression of viral genes by a virus carrying cDNA copies of ICP0 is delayed by several hours. Ultimately, however, the synthesis of proteins and accumulation of virions in mutant-infected cells catches up with those of wild-type virus-infected cells (34). One interpretation of the delay is that the synthesis of ICP0 directed by the cDNA copy is impaired and slower than that directed by the wild-type gene. Inhibitors of histone deacetylation accelerated the synthesis and accumulation of viral gene products in cells infected with the ICP0-cDNA mutant virus (26).
The second line of evidence is based on the earlier report that ICP0 binds CoREST/REST and dissociates this complex from HDAC1 and HDAC2. Sequentially, in wild-type virus-infected cells, the CoREST/REST complex and HDAC1/2 are independently transported to the cytoplasm. Furthermore, both HDAC1/2 and CoREST become posttranslationally modified (15, 26). It was also reported that ICP0 interacts physically with HDAC4, HDAC5, and HDAC7 (35).
The third line of evidence presented in this report centers on the gene expression of ΔICP0 mutant virus in SK-N-SH and in U2OS cells. At low multiplicity of infection, ΔICP0 mutant virus is arrested in SK-N-SH cells at α gene expression. We show that the transition to post-α gene expression can be induced by exposure of cells to sodium butyrate. In U2OS cells that are permissive for ΔICP0 mutants, the transition does not require sodium butyrate. In essence, sodium butyrate compensates at least in part for the absence of ICP0. These three series of experiments support the hypothesis that one function of ICP0 is to block the repression of the viral genome by histone deacetylation.
The hints that US3 and US3.5 protein kinases may play a similar role emerged from observations that both kinases mediated the phosphorylation of HDAC1 and HDAC2 (26, 27). In this report we show that both US3 and US3.5 protein kinases enable the expression of viral or cellular genes transduced into mammalian cells with the aid of baculoviruses. Concurrently, HDAC1 undergoes changes in intracellular distribution or amounts. The advantage of the baculovirus system is that it does not introduce into cells transcriptional factors active in mammalian cells, and, in most cell lines, expression of transduced reporter genes requires exposure to sodium butyrate. Our data show that cotransduction of US3 readily enables the expression of reporter genes in SK-N-SH cells and enhances the expression of transduced reporter genes in U2OS cells in the absence of sodium butyrate. It would appear that US3 and ICP0 share similar objectives to block the silencing of the viral genome, although the mechanisms by which these proteins accomplish their goals are different. Cotransduction of US3 or US3.5 protein kinase with a desired gene is a convenient and rapid way of expressing genes in mammalian cells in a dose-dependent manner. The accumulation of reporter gene product was observed as early as 6 h after transduction, and the amounts of protein continued to increase for at least 22 h (data not shown).
In essence, HSV encodes one site-specific transcriptional activator for α genes (VP16) and three proteins whose function is to block cellular silencing machinery (ICP0, US3, and US3.5). In addition, ICP4 acts as a sequence-specific repressor and as a sequence-independent transcriptional factor, based on the observations that in infected cells ICP4 does not transactivate post-α genes in the absence of ICP0 or sodium butyrate and that there is little homology among the DNA binding sites of ICP4 in post-α genes (3, 36). Moreover, post-β gene expression is enhanced by the modification of DNA templates by ICP8 (37). Viral gene expression is also measurably aided by the selective degradation of cellular mRNA by virion host shutoff protein encoded by UL41 and by inhibition of splicing by ICP27 (38, 39).
Last, the properties of U2OS cells that enable them to support the replication of ΔICP0 mutants remain a puzzle. The data suggest that U2OS cells are only partially effective in silencing HSV DNA upon release from capsids into the nucleus.
Materials and Methods
Cells and Viruses.
Protocols for U2OS (human osteosarcoma cells), SK-N-SH, and insect cell line Sf9 (Spodoptera frugiperda) were reported elsewhere (27, 40). The recombinant baculoviruses BC2820, BC2602, BC2608, BC2617 (US1.5), and BC2618 (US11) were described (24, 27, 41, 42). The properties and the derivation of deletion mutant R7910 (ΔICP0) were described elsewhere (40).
Antibodies.
Rabbit polyclonal antibodies against US3 and the carboxyl-terminal region of ICP22 (W2) and the mouse monoclonal antibody against Us11 were described previously (24). We purchased monoclonal antibodies against ICP4 and ICP8 from the Goodwin Cancer Research Institute (Plantation, FL), polyclonal antibody against HDAC1 and monoclonal antibody against actin and Flag-epitope antibody from Sigma, polyclonal antibody for CoREST and monoclonal antibody against HDAC1 from Upstate Biotechnology, and the monoclonal antibody against c-myc from Santa Cruz Biotechnology.
The methods for generation and amplification of recombinant baculoviruses, confocal microscopy, preparation of cell lysates, electrophoretic separation of proteins, and immunoblotting were previously described (26, 34, 43).
Plasmids for Construction of Recombinant Baculoviruses.
PRB5999, pRB6000, pRB6001, pRB6003, and pRB5914 were used for construction of baculoviruses BC2619 (5′ Flag-tagged cdc34 cut from pRB5997), BC2620 [5′ Flag-tagged HDAC4 cut from plasmid pBJ5.1-HDAC4 kindly provided by Bradley Bernstein (Harvard University, Cambridge, MA)], BC2623 [5′ Myc-tagged US3 amplified from HSV-1(F) viral DNA], BC2901 [5′ Myc-tagged UL34 amplified from pRB5709 (44)], and BC2621 [K220N US3 mutant kindly provided by J. Munger (Princeton University, Princeton, NJ)], respectively. The baculovirus transfer vector pRB5850 (42) was used for cloning cdc34, Myc-tagged US3, and K220N US3 mutant, MTS1-Myc (43) was used for UL34, and the StuI/SacI-collapsed of pRB5850 was used for HDAC4.
Acknowledgments
We thank Dr. Bradley Bernstein for the plasmid pBJ5.1-HDAC4, J. Munger for the plasmid pRB5914, and P. Desai for assistance in generating the baculovirus BC2901. These studies were aided by National Cancer Institute Grants CA87661, CA83939, CA71933, CA78766, and CA88860.
Abbreviations
- HDAC
histone deacetylase
- HSV
herpes simplex virus
- pfu
plaque-forming unit.
Footnotes
Conflict of interest statement: No conflicts declared.
References
- 1.Roizman B., Knipe D. M. In: Fields Virology. 4th Ed. Knipe D. M., Howley P., Griffin D. E., Lamb R. A., Martin M. A., Roizman B., Straus S. E., editors. New York: Lippincott Williams & Wilkins; 2001. pp. 2399–2459. [Google Scholar]
- 2.Yao F., Schaffer P. A. J. Virol. 1995;69:6249–6258. doi: 10.1128/jvi.69.10.6249-6258.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Roizman B., Gu H., Mandel G. Cell Cycle. 2005;4:1019–1021. doi: 10.4161/cc.4.8.1902. [DOI] [PubMed] [Google Scholar]
- 4.Everett R. D., Boutell C., Orr A. J. Virol. 2004;78:1763–1774. doi: 10.1128/JVI.78.4.1763-1774.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hobbs W. E., DeLuca N. A. J. Virol. 1999;73:8245–8255. doi: 10.1128/jvi.73.10.8245-8255.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Danaher R. J., Jacob R. J., Steiner M. R., Allen W. R., Hill J. M., Miller C. S. J. Neurovirol. 2005;11:306–317. doi: 10.1080/13550280590952817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Merezak C., Reichert M., Van Lint C., Kerkhofs P., Portetelle D., Willems L., Kettmann R. J. Virol. 2002;76:5034–5042. doi: 10.1128/JVI.76.10.5034-5042.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gwack Y., Byun H., Hwang S., Lim C., Choe J. J. Virol. 2001;75:1909–1917. doi: 10.1128/JVI.75.4.1909-1917.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lu F., Zhou J., Wiedmer A., Madden K., Yuan Y., Lieberman P. M. J. Virol. 2003;77:11425–11435. doi: 10.1128/JVI.77.21.11425-11435.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Grassi G., Maccaroni P., Meyer R., Kaiser H., D’Ambrosio E., Pascale E., Grassi M., Kuhn A., Di Nardo P., Kandolf R., et al. Carcinogenesis. 2003;24:1625–1635. doi: 10.1093/carcin/bgg118. [DOI] [PubMed] [Google Scholar]
- 11.Brooks A. R., Harkins R. N., Wang P., Qian H. S., Liu P., Rubanyi G. M. J. Gene Med. 2004;6:395–404. doi: 10.1002/jgm.516. [DOI] [PubMed] [Google Scholar]
- 12.Zhang Y., Jones C. J. Virol. 2001;75:9571–9578. doi: 10.1128/JVI.75.20.9571-9578.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tang Q., Maul G. G. J. Virol. 2003;77:1357–1367. doi: 10.1128/JVI.77.2.1357-1367.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nevels M., Paulus C., Shenk T. Proc. Natl. Acad. Sci. USA. 2004;101:17234–17239. doi: 10.1073/pnas.0407933101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gu H., Liang Y., Mandel G., Roizman B. Proc. Natl. Acad. Sci. USA. 2005;102:7571–7576. doi: 10.1073/pnas.0502658102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hagglund R., Roizman B. J. Virol. 2004;78:2169–2178. doi: 10.1128/JVI.78.5.2169-2178.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gelman I. H., Silverstein S. Proc. Natl. Acad. Sci. USA. 1985;82:5265–5269. doi: 10.1073/pnas.82.16.5265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.O’Hare P., Hayward G. S. J. Virol. 1985;53:751–760. doi: 10.1128/jvi.53.3.751-760.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Quinlan M. P., Knipe D. M. Mol. Cell. Biol. 1985;5:957–963. doi: 10.1128/mcb.5.5.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lin R., Noyce R. S., Collins S. E., Everett R. D., Mossman K. L. J. Virol. 2004;78:1675–1684. doi: 10.1128/JVI.78.4.1675-1684.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Eidson K. M., Hobbs W. E., Manning B. J., Carlson P., DeLuca N. A. J. Virol. 2002;76:2180–2191. doi: 10.1128/jvi.76.5.2180-2191.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Melroe G. T., DeLuca N. A., Knipe D. M. J. Virol. 2004;78:8411–8420. doi: 10.1128/JVI.78.16.8411-8420.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Chee A. V., Lopez P., Pandolfi P. P., Roizman B. J. Virol. 2003;77:7101–7105. doi: 10.1128/JVI.77.12.7101-7105.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Poon A. P. W., Roizman B. J. Virol. 2005;79:8470–8479. doi: 10.1128/JVI.79.13.8470-8479.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Benetti L., Roizman B. Proc. Natl. Acad. Sci. USA. 2004;101:9411–9416. doi: 10.1073/pnas.0403160101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Poon A. P., Liang Y., Roizman B. J. Virol. 2003;77:12671–12678. doi: 10.1128/JVI.77.23.12671-12678.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Poon A. P. W., Benetti L., Roizman B. J. Virol. 2006;80:3752–3764. doi: 10.1128/JVI.80.8.3752-3764.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Leopardi R., Van Sant C., Roizman B. Proc. Natl. Acad. Sci. USA. 1997;94:7891–7896. doi: 10.1073/pnas.94.15.7891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jerome K. R., Fox R., Chen Z., Sears A. E., Lee H., Corey L. J. Virol. 1999;73:8950–8957. doi: 10.1128/jvi.73.11.8950-8957.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Munger J., Chee A. V., Roizman B. J. Virol. 2001;75:5491–5497. doi: 10.1128/JVI.75.12.5491-5497.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Munger J., Roizman B. Proc. Natl. Acad. Sci. USA. 2001;98:10410–10415. doi: 10.1073/pnas.181344498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ogg P. D., McDonell P. J., Ryckman B. J., Knudson C. M., Roller R. J. Virology. 2004;319:212–224. doi: 10.1016/j.virol.2003.10.019. [DOI] [PubMed] [Google Scholar]
- 33.Condreay J. P., Witherspoon S. M., Clay W. C., Kost T. A. Proc. Natl. Acad. Sci. USA. 1999;96:127–132. doi: 10.1073/pnas.96.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Poon A. P., Silverstein S. J., Roizman B. J. Virol. 2002;76:9744–9755. doi: 10.1128/JVI.76.19.9744-9755.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lomonte P., Thomas J., Texier P., Caron C., Khochbin S., Epstein A. L. J. Virol. 2004;78:6744–6757. doi: 10.1128/JVI.78.13.6744-6757.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Michael N., Spector D., Mavromara-Nazos P., Kristie T. M., Roizman B. Science. 1988;239:1,531–1,534. doi: 10.1126/science.2832940. [DOI] [PubMed] [Google Scholar]
- 37.Taylor T. J., Knipe D. M. J. Virol. 2004;78:5856–5866. doi: 10.1128/JVI.78.11.5856-5866.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kwong A. D., Frenkel N. Proc. Natl. Acad. Sci. USA. 1987;84:1926–1930. doi: 10.1073/pnas.84.7.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hardy W. R., Sandri-Goldin R. M. J. Virol. 1994;68:7790–7799. doi: 10.1128/jvi.68.12.7790-7799.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lopez P., Jacob R. J., Roizman B. J. Virol. 2002;76:9355–9367. doi: 10.1128/JVI.76.18.9355-9367.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hagglund R., Munger J., Poon A. P., Roizman B. J. Virol. 2002;76:743–754. doi: 10.1128/JVI.76.2.743-754.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sciortino M. T., Taddeo B., Poon A. P., Mastino A., Roizman B. Proc. Natl. Acad. Sci. USA. 2002;99:8318–8323. doi: 10.1073/pnas.122231699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Gu H., Roizman B. Proc. Natl. Acad. Sci. USA. 2003;100:8963–8968. doi: 10.1073/pnas.1533420100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ye G. J., Roizman B. Proc. Natl. Acad. Sci. USA. 2000;97:11002–11007. doi: 10.1073/pnas.97.20.11002. [DOI] [PMC free article] [PubMed] [Google Scholar]





